Q60K (p.Gln60Lys) variant of MERTK (Tyrosine-protein kinase Mer)
Q60K (p.Gln60Lys) in MERTK (Tyrosine-protein kinase Mer) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes structural context.
Q60K (p.Gln60Lys) variant details
- p.Gln60Lys
- rs376885459
- cosmic curated COSV99775
- ESP rs376885459
- TOPMed rs376885459
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.305
- AlphaMissense 0.08
- MetaLR 0.19
- MetaSVM -0.85
- PolyPhen-2 0.64
- SIFT 0.02
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available